Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
PhishPharm - Detail
FDA Home
PhishPharm
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Title:
Bioavailability of oxolinic acid in Atlantic salmon (Salmo salar L.) from medicated feed.
Authors:
Hustvedt SO, Salte R, Kvendset O, Vassvik V
Drug:
Oxolinic acid
Fish species:
Salmon, Atlantic
Date:
1991
t1/2-hr:
96
est:
est
Sample:
blood, serum
Ave Weight (gm):
932
Ave Water temp (°C):
8
Water:
Saltwater
Dosage:
26 mg/kg sd
Route:
PO
Comments:
Bioavailability=20% . T 1/2 est from table. Mean serum concentrations ug/ml after oral dose - 6h=10.91, 9h=1.55, 12h=1.76, 24h=1.98, 48h- 1.85, 96h=1.04, 144h=0.51, 192h=0.19, 240=nd. Cmax=2.1 mg/ml at 243.3 h. Salinity 25%.
Citation:
Aquaculture 97:305-310
Link:
http://dx.doi.org/10.1016/0044-8486(91)90322-X
Genus Species:
Salmo salar
Drug Class:
Antibiotic-Quinolone
t1/2-detail:
<96 h est from table
Wt gm-detail:
932+/-230 g
Water temp (°C)-detail:
7.5 C
Dosage-detail:
26 mg/kg sd
Method:
HPLC
Authors-red:
Hustvedt SO, Salte R, Kvendset O, Vassvik V
-
-